OGN Organon & Co

添加自選

8.040
-0.400-4.74%

收盤價 05/14 16:00 (美東)

8.090
+0.050+0.62%

盤前 08:31 (美東)

20.90億總市值2.79市盈率TTM

關於Organon & Co公司

Organon & Co是一家以科學爲基礎的製藥公司，通過女性健康、生物仿製藥和知名品牌的處方療法組合開發和提供健康解決方案。該公司的業務包括以下產品組合：女性健康，生物仿製藥和既定藥物。從地理上看，公司的大部分收入來自歐洲和加拿大，其次是美國，然後是亞太地區和日本。該公司的大部分收入來自知名品牌產品組合。

公司介紹

公司代碼OGN

公司名稱Organon & Co

上市日期2021/05/14

成立日期2020

CEOMr. Kevin Ali

所屬市場紐交所

員工數量10000

年結日12-31

公司地址30 Hudson Street,33rd floor

城市Jersey City

省份新澤西

國家美國

郵編07302

電話1-551-430-6900

網址http://www.organon.com

董事高管

姓名
職務
年薪

Kevin Ali
Chief Executive Officer and Director
1711.74萬

Rachel A. Stahler
Executive Vice President and Chief Digital & Growth Officer
--

Matthew M. Walsh
Executive Vice President, Chief Financial Officer and Principal Accounting Officer
574.69萬

Aaron Falcione
Executive Vice President and Chief Human Resources Officer
--

Dr. Juan Camilo Arjona Ferreira, M.D.
Executive Vice President, Head of Research and Development and Chief Medical Officer
359.98萬

Kathryn DiMarco
Senior Vice President and Corporate Controller
--

Vittorio Nisita
Executive Vice President and Head of Enterprise Services & Solutions
--

Kirke Weaver
Executive Vice President, General Counsel and Corporate Secretary
--

Joseph T. Morrissey, Jr
Executive Vice President and Head of Manufacturing and Supply
412.99萬

Daniel Karp
Executive Vice President, Corporate Development
--

Carrie S. Cox
Chairman of the Board
45.00萬

Ramona A. Sequeira
Director
--

Shalini Sharp
Independent Director
34.50萬

Rochelle B. Lazarus
Independent Director
32.00萬

Grace Puma Whiteford
Independent Director
32.00萬

Deborah R. Leone
Independent Director
33.00萬

Cynthia M. Patton
Independent Director
33.00萬

Robert A. Essner
Independent Director
33.50萬

Dr. Philip Ozuah, M.D.,PhD
Independent Director
33.41萬

Dr. Helene D. Gayle, M.D.
Independent Director
32.00萬

Dr. Alan Ezekowitz, M.D.,PhD
Independent Director
33.00萬

OGN Organon & Co

關於Organon & Co公司

公司介紹

董事高管

熱門市場機會

快訊7*24

投資課程

重估中國資產

熱門討論